XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current Assets    
Cash $ 23,785,771 $ 35,004,924
Accounts receivable 9,244,321 10,854,084
Product deposit 370,518 40,763
Inventory 3,432,382 2,797,358
Other current assets 4,252,613 3,672,231
Total Current Assets 41,085,605 52,369,360
Non-current Assets    
Equipment, net 2,584,829 1,479,184
Right of use assets, net 5,578,992 6,400,596
Capitalized Computer Software, Net 15,175,634 13,816,501
Intangible assets, net 1,558,318 2,030,656
Total Non-current Assets 24,897,773 23,726,937
Total Assets 65,983,378 76,096,297
Current Liabilities    
Accounts payable 19,554,735 16,009,484
Accrued expenses 22,079,805 22,811,763
Current operating lease liabilities 673,482 508,537
Current portion of convertible long-term debt 8,444,444
Deferred revenue 14,355,531 19,625,940
Total Current Liabilities 56,663,553 67,400,168
Long-term Liabilities    
Convertible long-term debt, net 9,885,057
Noncurrent operating lease liabilities 5,851,673 6,265,192
Contingent consideration 100,000 100,000
Total Liabilities 62,615,226 83,650,417
Commitments and contingencies (Note 11)  
Stockholders’ Equity (Deficit)    
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $35.8 million as of September 30, 2025 and December 31, 2024 140 140
Common Stock, $0.01 par value; 100,000,000 shares authorized, 46,686,350 and 42,293,907 shares issued, 46,583,310 and 42,190,867 outstanding as of September 30, 2025 and December 31, 2024, respectively 466,864 422,939
Additional paid-in capital 248,801,209 230,508,339
Accumulated deficit (247,790,178) (239,850,931)
Treasury stock, 103,040, at cost, as of September 30, 2025 and December 31, 2024 (163,701) (163,701)
Total LifeMD, Inc. Stockholders’ Equity (Deficit) 1,314,334 (9,083,214)
Non-controlling interest 2,053,818 1,529,094
Total Stockholders’ Equity (Deficit) 3,368,152 (7,554,120)
Total Liabilities and Stockholders’ Equity (Deficit) $ 65,983,378 $ 76,096,297